1. Home
  2. ROOT vs ALVO Comparison

ROOT vs ALVO Comparison

Compare ROOT & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROOT
  • ALVO
  • Stock Information
  • Founded
  • ROOT 2015
  • ALVO 2013
  • Country
  • ROOT United States
  • ALVO Luxembourg
  • Employees
  • ROOT N/A
  • ALVO N/A
  • Industry
  • ROOT Property-Casualty Insurers
  • ALVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ROOT Finance
  • ALVO Health Care
  • Exchange
  • ROOT Nasdaq
  • ALVO Nasdaq
  • Market Cap
  • ROOT 2.3B
  • ALVO 2.5B
  • IPO Year
  • ROOT 2020
  • ALVO N/A
  • Fundamental
  • Price
  • ROOT $80.94
  • ALVO $8.63
  • Analyst Decision
  • ROOT Buy
  • ALVO Strong Buy
  • Analyst Count
  • ROOT 6
  • ALVO 1
  • Target Price
  • ROOT $130.60
  • ALVO $14.00
  • AVG Volume (30 Days)
  • ROOT 488.8K
  • ALVO 361.1K
  • Earning Date
  • ROOT 10-29-2025
  • ALVO 11-12-2025
  • Dividend Yield
  • ROOT N/A
  • ALVO N/A
  • EPS Growth
  • ROOT N/A
  • ALVO N/A
  • EPS
  • ROOT 4.73
  • ALVO 0.22
  • Revenue
  • ROOT $1,364,700,000.00
  • ALVO $562,478,000.00
  • Revenue This Year
  • ROOT $27.41
  • ALVO $36.61
  • Revenue Next Year
  • ROOT $9.74
  • ALVO $42.26
  • P/E Ratio
  • ROOT $17.31
  • ALVO $39.49
  • Revenue Growth
  • ROOT 59.76
  • ALVO 82.19
  • 52 Week Low
  • ROOT $36.87
  • ALVO $7.35
  • 52 Week High
  • ROOT $181.14
  • ALVO $13.70
  • Technical
  • Relative Strength Index (RSI)
  • ROOT 33.20
  • ALVO 57.22
  • Support Level
  • ROOT $89.55
  • ALVO $8.03
  • Resistance Level
  • ROOT $92.27
  • ALVO $8.44
  • Average True Range (ATR)
  • ROOT 4.42
  • ALVO 0.30
  • MACD
  • ROOT -1.30
  • ALVO 0.06
  • Stochastic Oscillator
  • ROOT 1.57
  • ALVO 55.33

About ROOT Root Inc.

Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.

About ALVO Alvotech

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.

Share on Social Networks: